AETHERA
Lab Background
Genomic R&D
Protocol v4.2 Active

Next - Gen
Tech + Precision

Engineering the future of medicine through synthetic biology, computational genetics, and unprecedented molecular therapeutics.

Researcher Researcher Researcher
+124
Lead Investigators
Global Network
ESTABLISHED
2012
Foundation of excellence
INFRASTRUCTURE
50 K
Sq. Ft. Advanced Lab Space
ACCREDITATION
CLIA +CAP
Internationally Certified
CAPABILITIES.MATRIX

Advanced Solutions
For Life Sciences

ID: NGS-001.X
Next-Gen Sequencing
High-Throughput

Next-Gen Sequencing

Advanced genomic screening systems ensuring ultra-accurate, rapid turnaround for clinical and research applications with multi-omics integration.

PRT-SYN ISO-9001

Custom Protein
Synthesis

Tailored engineering services meeting strict tolerances for therapeutic and diagnostic pipelines.

Cell Culturing

High-Viability

Cell Culturing

Automation Lab
[SYS_ROBOTIC]

State-of-the-Art
Robotic Assays

Integrating advanced robotics into liquid handling processes for unparalleled consistency, throughput speed, and safety in high-volume screening operations.

Discover Platform
Robotics Lab
CORPORATE.ETHOS

A Legacy of
Discovery

Microscope Research
MAG: 4000x
FOCUS LOCK
Bioinformatics
Data Analysis & Modeling
01

Our Scientists

With over 100 PhD researchers and technicians, we combine deep scientific expertise with computational innovation to deliver exceptional breakthroughs.

02

Commitment to Ethics

Committed to patient success by maintaining the highest ethical standards in all clinical and pre-clinical trials, surpassing regulatory safety protocols.

03

Certifications & Standards

Proudly holding CLIA, CAP, and ISO-9001 certifications, a testament to our rigorous Quality Management System and laboratory excellence.

INFRASTRUCTURE

State-Of-The-Art
Lab In Boston

Spanning an impressive 50,000 square feet, our facility houses high-throughput sequencers, a dedicated BSL-3 environment, and serves as the epicenter of biological innovation.

Lab Facility
Microscope Slide
Live Feed // Cam 04

CRISPR Gene Editing

TGT-ACC
48.2µm
Applications.Matrix

Impact Spanning
Multiple Disciplines

Active R&D
142
+
Specialized Scientists
Oncology
45%
Agri-Bio
35%
Immunology
20%
Phase III

Therapeutics & Oncology

Precision Targeted

Serving clinical researchers to develop reliable treatments for critical genomic disorders, utilizing high-tolerance immunotherapies.

Binding Affinity
Kd < 1pM
Toxicity Level
Grade 1
Clinical Efficacy 99.9%
Patent

Agricultural & SynBio

Climate Resilience

Supporting global food security with engineered drought-resistant traits, alongside discovering sustainable bio-based alternatives.

Drought-Resist Pest Immunity N2 Fixation
Yield Multiplier 3.4x Baseline
Cur

Pushing the
Boundaries of
Bioscience. Bioscience.

Connect with our lead investigators to discuss assay specifications, target sequences, and research timelines for your next clinical program.

End-to-end Encrypted
Secure Channel

Request Consultation

Form_01
Require bilateral Non-Disclosure Agreement (NDA) prior to technical review.